1. Ukuxilongwa kanye nokwelashwa kwe-COVID-19 (Trial version 8) yiKhomishini Yezempilo Kazwelonke ye-PRC
Ingcuphe ye-thromboembolism iphezulu ezigulini ezinzima noma ezibucayi, ……, ama-Anticoagulants kufanele asetshenziswe ngokufanele. Uma kwenzeka i-thromboembolism, ukwelashwa kwe-anticoagulant kufanele kwenziwe ngokuya ngemikhombandlela ehambisanayo.

2. — Ukutheleleka KWE-CELL SARS-CoV-2 Kuya nge-Cellular Heparan Sulfate ne-ACE2, i-Heparin kanye ne-non-anticoagulant derivatives evimba ukubopha nokutheleleka kwe-SARSCoV-2.

Ukwelashwa okuwukuphela kokusetshenziswa kabanzi kule ndawo umthamo wokuvimbela we-molecular weight heparin (LMWH), okufanele ucatshangelwe kuzo zonke iziguli ezibhedlela ezine-pneumonia entsha ye-coronary (kufaka phakathi iziguli ezingabucayi) ngaphandle kokuphikisana.
Isiqondisi sesikhashana se-ISTH ekwamukelweni nasekuphathweni kwe-coagulopathy ku-COVID-19

Ezigulini (abadala nentsha) ezibhedlela nge-COVID-19, sebenzisa i-pharmacological prophylaxis, njenge-low molecular weight heparin (njenge-enoxaparin), ngokuya ngamazinga endawo nawamazwe omhlaba, ukuvimbela i-venous thromboembolism, uma ingaphikiswa.

5. Zonke iziguli ezine-COVID-19 ebucayi futhi ebucayi, engcupheni yokopha okuphansi noma elinganiselayo, futhi akukho okuphikisanayo okunconywayo ukusebenzisa imishanguzo ukuvimbela i-VTE, futhi i-heparin enesisindo esiphansi ukukhetha kuqala; ngokungasebenzi kahle kwezinso, kunconywa i-heparin engakhiphiwe.
Ezigulini ezimnene nezijwayelekile, uma kunengozi enkulu noma elinganiselayo ye-VTE, ukuvimbela izidakamizwa kuyanconywa ngemuva kokuqedwa kokuphikisana, futhi i-heparin yamangqamuzana aphansi ukhetho lokuqala.

Ukuvimbela nokwelashwa kwe-Venous Thromboembolism Ehambisana Ne-Coronavirus Disease 2019 Infection: Isitatimende Sokuvumelana Ngaphambi Kwezinkombandlela